Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,891 | 202 | 98.7% |
| Education | $53.17 | 4 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,355 | 71 | $0 (2024) |
| Hologic Sales and Service, LLC | $330.06 | 12 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $327.02 | 18 | $0 (2023) |
| PFIZER INC. | $312.40 | 21 | $0 (2024) |
| Astellas Pharma US Inc | $279.21 | 16 | $0 (2024) |
| Hologic, LLC | $185.54 | 8 | $0 (2022) |
| Myovant Sciences Inc. | $164.73 | 11 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $134.10 | 7 | $0 (2024) |
| Medtronic, Inc. | $123.69 | 3 | $0 (2024) |
| MAYNE PHARMA COMMERCIAL LLC | $95.88 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $462.44 | 25 | Hologic Sales and Service, LLC ($172.86) |
| 2023 | $847.45 | 41 | AbbVie Inc. ($201.49) |
| 2022 | $848.61 | 45 | ABBVIE INC. ($232.37) |
| 2021 | $898.91 | 41 | AbbVie Inc. ($475.11) |
| 2020 | $186.67 | 12 | AbbVie Inc. ($83.00) |
| 2019 | $373.97 | 21 | AbbVie, Inc. ($221.15) |
| 2018 | $287.72 | 18 | AbbVie, Inc. ($111.69) |
| 2017 | $38.54 | 3 | AMAG Pharmaceuticals, Inc. ($13.66) |
All Payment Transactions
206 individual payment records from CMS Open Payments — Page 9 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/08/2018 | Bayer HealthCare Pharmaceuticals Inc. | Kyleena (Drug), Mirena | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: Women's Health | ||||||
| 03/12/2018 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $12.81 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 02/19/2018 | Duchesnay USA Incorporated | Osphena (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: Women's Health | ||||||
| 10/20/2017 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $13.66 | General |
| Category: INTRAROSA | ||||||
| 08/07/2017 | Duchesnay USA Incorporated | Diclegis (Drug) | Food and Beverage | Cash or cash equivalent | $11.53 | General |
| Category: Pre Natal Care | ||||||
| 06/06/2017 | AbbVie, Inc. | Lupron (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 96 | 104 | $11,273 | $5,033 |
| 2022 | 4 | 87 | 93 | $9,164 | $4,053 |
| 2021 | 5 | 123 | 132 | $13,044 | $6,279 |
| 2020 | 4 | 79 | 82 | $9,986 | $3,074 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 39 | $4,485 | $2,181 | 48.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $3,083 | $1,235 | 40.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 29 | 29 | $2,175 | $1,035 | 47.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 18 | $1,530 | $581.84 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 35 | $4,013 | $1,990 | 49.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 29 | 29 | $2,206 | $1,049 | 47.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 17 | $1,445 | $544.97 | 37.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 12 | 12 | $1,500 | $469.36 | 31.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 50 | $5,306 | $2,628 | 49.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 38 | 38 | $2,850 | $1,411 | 49.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 15 | 15 | $2,508 | $1,088 | 43.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 15 | 15 | $630.00 | $615.45 | 97.7% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 14 | 14 | $1,750 | $536.88 | 30.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 32 | 35 | $4,743 | $1,320 | 27.8% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 16 | 16 | $2,105 | $805.08 | 38.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 18 | 18 | $2,001 | $671.07 | 33.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 13 | 13 | $1,137 | $277.70 | 24.4% |
About Dr. Ashley Robbins, MD
Dr. Ashley Robbins, MD is a Obstetrics & Gynecology healthcare provider based in Wichita, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2008. The National Provider Identifier (NPI) number assigned to this provider is 1699932541.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashley Robbins, MD has received a total of $3,944 in payments from pharmaceutical and medical device companies, with $462.44 received in 2024. These payments were reported across 206 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,891).
As a Medicare-enrolled provider, Robbins has provided services to 385 Medicare beneficiaries, totaling 411 services with total Medicare billing of $18,439. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Wichita, KS
- Active Since 05/19/2008
- Last Updated 08/31/2020
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1699932541
Products in Payments
- LILETTA (Drug) $372.26
- MYFEMBREE (Drug) $298.83
- Kyleena (Drug) $291.68
- PREMARIN (Drug) $291.41
- Orilissa (Drug) $288.99
- LO LOESTRIN FE (Drug) $262.78
- Veozah (Drug) $247.02
- ORIAHNN (Drug) $226.55
- ORILISSA (Drug) $147.07
- CoolSeal Generator (Device) $136.59
- TRUCLEAR (Device) $123.69
- APTIMA (Device) $119.72
- NEXTSTELLIS (Drug) $95.88
- Paragard (Device) $94.32
- ACESSA PROVU SYSTEM (Device) $85.24
- Twirla (Drug) $76.40
- THINPREP 2000 PROCESSOR (Device) $70.53
- INJECTAFER (Drug) $58.11
- Da Vinci Surgical System (Device) $58.05
- INTRAROSA (Drug) $53.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Wichita
Zachary Kuhlmann, Do, DO
Obstetrics & Gynecology — Payments: $14,989
Edmond Feuille, Md, MD
Obstetrics & Gynecology — Payments: $8,800
Janna Chibry, Md, MD
Obstetrics & Gynecology — Payments: $8,259
Melissa Hodge, Md, MD
Obstetrics & Gynecology — Payments: $7,495
Carl Christman, Md, MD
Obstetrics & Gynecology — Payments: $5,785
Damen Hershberger, M.d, M.D
Obstetrics & Gynecology — Payments: $5,708